Income Statement Nikon Corporation

Stocks

7731

JP3657400002

Household Electronics

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-06-10 am EDT			5-day change	1st Jan Change
1,825.00 ^JPY	-1.00%		-8.84%	+4.64%

Jun. 03	Japan's Nikkei closes above 68,000 mark as AI stocks surge	RE
May. 29	Nikon Eyes Lithography Comeback With Price Play Against ASML	MT

e8de2e7c834ce00b1f55a36ea5488f3d.__cOTAXHUFMl5yOWEb33QXF5h1Gc6Eeoxe7vMVM2-mQ.rJFsIkLyIiVui3D0X_uZMzBLsDTopgrkh4yNXD59lgOUpFY4aLI1YGqicg

Published financial data: NIKON CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	451B	540B	628B	717B	715B
Total Revenues	451B	540B	628B	717B	715B
Cost of Goods Sold, Total	295B	304B	339B	407B	403B
Gross Profit	156B	236B	289B	310B	312B
Selling General & Admin Expenses, Total	111B	118B	150B	178B	197B
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	58.79B	59.88B	67.58B	71.14B	74.55B
Depreciation & Amortization - (IS)	11.83B	11.32B	13.95B	19.2B	23.79B
Other Operating Expenses	2.12B	456M	174M	-74M	1.64B
Other Operating Expenses, Total	183B	190B	231B	268B	297B
Operating Income	-27.55B	46.15B	57.77B	42.06B	15.17B
Interest Expense, Total	-1.25B	-1.05B	-1.98B	-3.2B	-2.68B
Interest And Investment Income	2.73B	2.16B	4.18B	5.61B	5.47B
Net Interest Expenses	1.48B	1.11B	2.2B	2.41B	2.79B
Income (Loss) On Equity Invest.	1.97B	1.21B	2.54B	2.47B	3.15B
Currency Exchange Gains (Loss)	612M	-2.29B	-3.85B	-4.41B	-3.16B
Other Non Operating Income (Expenses)	1.4B	473M	1.26B	475M	718M
EBT, Excl. Unusual Items	-22.1B	46.66B	59.92B	43.01B	18.66B
Restructuring Charges	-4.34B	-	-	-	-4.92B
Gain (Loss) On Sale Of Investments	7.69B	6.49B	302M	2.06B	392M
Gain (Loss) On Sale Of Assets	141M	3.54B	267M	-217M	35M
Asset Writedown	-26.73B	408M	-3.43B	-2.19B	-9.63B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-45.34B	57.1B	57.06B	42.67B	4.53B
Income Tax Expense	-10.83B	14.84B	13.78B	10.54B	-1.59B
Earnings From Continuing Operations	-34.51B	42.25B	43.28B	32.13B	6.12B
Net Income to Company	-34.51B	42.25B	43.28B	32.13B	6.12B
Minority Interest	13M	426M	1.66B	436M	-
Net Income - (IS)	-34.5B	42.68B	44.94B	32.57B	6.12B
Net Income to Common Incl Extra Items	-34.5B	42.68B	44.94B	32.57B	6.12B
Net Income to Common Excl. Extra Items	-34.5B	42.68B	44.94B	32.57B	6.12B
Per Share Items
Net EPS - Basic	-93.96	116.23	125.46	94.03	17.86
Basic EPS - Continuing Operations	-93.96	116.23	125.46	94.03	17.86
Basic Weighted Average Shares Outstanding	367M	367M	358M	346M	343M
Net EPS - Diluted	-93.96	115.58	124.77	93.53	17.77
Diluted EPS - Continuing Operations	-93.96	115.58	124.77	93.53	17.77
Diluted Weighted Average Shares Outstanding	367M	369M	360M	348M	345M
Normalized Basic EPS	-37.58	80.57	109.17	78.87	34.02
Normalized Diluted EPS	-37.58	80.13	108.58	78.45	33.84
Dividend Per Share	20	40	45	50	50
Payout Ratio	-21.31	25.83	32.31	53.15	282.88
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	474M	71.01B	86.83B	77.73B	59.36B
EBITA	-27.55B	46.15B	57.77B	42.06B	15.17B
EBIT	-27.55B	46.15B	57.77B	42.06B	15.17B
Effective Tax Rate - (Ratio)	23.89	26	24.14	24.69	-35.08
Normalized Net Income	-13.8B	29.59B	39.11B	27.32B	11.66B
Non-Cash Pension Expense	2.39B	2.76B	2.54B	2.44B	2.69B
Supplemental Operating Expense Items
Advertising Expense	11.96B	13.93B	18.13B	23.27B	25.63B
Selling and Marketing Expenses	11.96B	13.93B	18.13B	23.27B	25.63B
Research And Development Expense From Footnotes	59.96B	61.11B	70.09B	76.52B	80.14B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	352B	370B	211B	207B	164B
Total Cash And Short Term Investments	352B	370B	211B	207B	164B
Accounts Receivable, Total	72.9B	90.57B	114B	140B	125B
Total Receivables	72.9B	90.57B	114B	140B	125B
Inventory	236B	239B	277B	285B	308B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	15.4B	14.42B	15.02B	35.54B	23.66B
Total Current Assets	676B	714B	618B	667B	620B
Net Property Plant And Equipment	98.44B	111B	125B	158B	165B
Long-term Investments	108B	113B	112B	112B	101B
Goodwill	20.55B	24.28B	73.83B	83.68B	83.46B
Other Intangibles, Total	23.51B	25.09B	65.65B	74.89B	82B
Deferred Tax Assets Long-Term	62.96B	51.61B	56.65B	51.47B	58.61B
Other Long-Term Assets, Total	1M	-1M	-1M	-1M	-1M
Total Assets	990B	1,040B	1,050B	1,147B	1,111B
Liabilities
Accounts Payable, Total	60.62B	65.16B	68.03B	83.65B	82.2B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	9.95B	23.35B	13.88B	55.09B	45.82B
Current Portion of Long-Term Debt	19.99B	14B	12.51B	33.22B	25.59B
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	1.43B	4.77B	8.84B	5.06B	5.47B
Other Current Liabilities	226B	207B	174B	153B	146B
Total Current Liabilities	318B	314B	277B	330B	306B
Long-Term Debt	104B	92.72B	108B	78.39B	122B
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	9.9B	5.54B	6.62B	7.33B	7.9B
Deferred Tax Liability Non Current	3.05B	3.36B	15.39B	16.63B	11.35B
Other Non Current Liabilities	15.62B	24.06B	24.98B	29.25B	24.35B
Total Liabilities	451B	440B	432B	462B	471B
Common Stock, Total	65.48B	65.48B	65.48B	65.48B	65.48B
Additional Paid In Capital	46.42B	46.48B	7.05B	897M	-
Retained Earnings	457B	501B	527B	549B	513B
Treasury Stock	-17.53B	-17.4B	-7.71B	-7.3B	-7.76B
Comprehensive Income and Other	-14.13B	2.2B	23B	75.88B	67.15B
Total Common Equity	538B	598B	615B	684B	638B
Minority Interest	1.14B	2.28B	3.38B	1.3B	1.25B
Total Equity	539B	600B	618B	685B	639B
Total Liabilities And Equity	990B	1,040B	1,050B	1,147B	1,111B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	367M	366M	346M	346M	329M
ECS Total Common Shares Outstanding	367M	367M	346M	346M	329M
Book Value / Share	1.46K	1.63K	1.78K	1.97K	1.94K
Tangible Book Value	494B	548B	475B	525B	473B
Tangible Book Value Per Share	1.34K	1.49K	1.37K	1.52K	1.44K
Total Debt	134B	130B	134B	167B	194B
Net Debt	-218B	-240B	-77.32B	-39.94B	29.98B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-9.41B	-19.52B	-19.61B	-32.05B	-36.61B
Minority Interest, Total (Incl. Fin. Div)	1.14B	2.28B	3.38B	1.3B	1.25B
Equity Method Investments, Total	11.1B	10.7B	10.31B	9.73B	10.07B
Inventories - Raw Materials, Total	34.24B	41.25B	52.42B	57.55B	64.81B
Inventories - Work In Process, Total	91.78B	96.3B	108B	118B	126B
Inventories - Finished Goods, Total	110B	101B	117B	109B	117B
Inventories - Others	-1M	-	-	-	1M
Full Time Employees	19.45K	18.44K	18.79K	19.44K	20.07K
Accumulated Allowance for Doubtful Accounts (Supple)	1.44B	788M	1B	1.12B	1.18B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-45.34B	57.1B	57.06B	42.67B	4.53B
Depreciation & Amortization - CF	28.03B	24.86B	29.06B	35.67B	44.19B
Depreciation & Amortization, Total	28.03B	24.86B	29.06B	35.67B	44.19B
(Gain) Loss From Sale Of Asset	25.91B	-3.09B	4.12B	2.93B	10.78B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-1.97B	-1.21B	-2.54B	-2.47B	-3.15B
Other Operating Activities, Total	-4.95B	-3.6B	-9.48B	-13.88B	-5.22B
Change In Accounts Receivable	17.27B	-13.32B	-15.5B	-17.27B	15.3B
Change In Inventories	13.12B	2.18B	-28.84B	4.91B	-20.04B
Change In Accounts Payable	-9.62B	3.07B	895M	5.99B	-1.65B
Change in Other Net Operating Assets	-17.5B	-34.63B	-34.75B	-27.78B	3.52B
Cash from Operations	4.97B	31.35B	15M	30.77B	48.26B
Capital Expenditure	-16.96B	-17.98B	-23.14B	-39.21B	-52.16B
Sale of Property, Plant, and Equipment	681M	5.48B	381M	763M	405M
Cash Acquisitions	-	-378M	-76.88B	-2.29B	-12.01B
Divestitures	-	-	8M	-	-
Sale (Purchase) of Intangible assets	-6.13B	-5.84B	-9.88B	-16B	-17.5B
Investment in Marketable and Equity Securities, Total	39.48B	16.24B	-3.52B	15.34B	10.78B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	960M	2.1B	881M	-	497M
Cash from Investing	18.02B	-385M	-112B	-41.4B	-69.99B
Short Term Debt Issued, Total	-	13.19B	-	40.06B	-
Long-Term Debt Issued, Total	19.89B	-	23.9B	-	69.49B
Total Debt Issued	19.89B	13.19B	23.9B	40.06B	69.49B
Short Term Debt Repaid, Total	-	-	-9.62B	-	-9.23B
Long-Term Debt Repaid, Total	-10B	-20.8B	-17.81B	-12.54B	-34.01B
Total Debt Repaid	-10B	-20.8B	-27.44B	-12.54B	-43.24B
Repurchase of Common Stock	-1M	-2M	-30B	-3M	-30B
Common Dividends Paid	-7.35B	-11.02B	-14.52B	-17.31B	-17.32B
Common & Preferred Stock Dividends Paid	-7.35B	-11.02B	-14.52B	-17.31B	-17.32B
Other Financing Activities, Total	-7.53B	-7.51B	-8.14B	-19.15B	1.27B
Cash from Financing	-4.99B	-26.15B	-56.21B	-8.94B	-19.81B
Foreign Exchange Rate Adjustments	9.77B	13.66B	9.4B	14.88B	-1.52B
Miscellaneous Cash Flow Adjustments	-	-1M	-	-	-
Net Change in Cash	27.76B	18.48B	-159B	-4.69B	-43.05B
Supplemental Items
Cash Interest Paid	1.25B	1.12B	1.77B	3.02B	2.63B
Cash Income Tax Paid (Refund)	5.82B	5.28B	12.47B	17.28B	8.2B
Levered Free Cash Flow	-4.8B	-2.45B	-57.37B	-58.21B	-21.57B
Unlevered Free Cash Flow	-4.02B	-1.79B	-56.13B	-56.22B	-19.9B
Change In Net Working Capital	-8.27B	31.67B	88.27B	62.96B	3.9B
Net Debt Issued / Repaid	9.89B	-7.61B	-3.54B	27.52B	26.25B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-1.73	2.84	3.46	2.39	0.84
Return on Total Capital	-2.57	4.11	4.87	3.28	1.13
Return On Equity %	-6.39	7.42	7.11	4.93	0.92
Return on Common Equity	-6.4	7.52	7.41	5.02	0.93
Margin Analysis
Gross Profit Margin %	34.55	43.75	46.04	43.23	43.61
SG&A Margin	24.54	21.92	23.83	24.78	27.52
EBITDA Margin %	0.1	13.16	13.82	10.84	8.3
EBITA Margin %	-6.11	8.55	9.2	5.86	2.12
EBIT Margin %	-6.11	8.55	9.2	5.86	2.12
Income From Continuing Operations Margin %	-7.65	7.83	6.89	4.48	0.86
Net Income Margin %	-7.65	7.91	7.16	4.54	0.86
Net Avail. For Common Margin %	-7.65	7.91	7.16	4.54	0.86
Normalized Net Income Margin	-3.06	5.48	6.23	3.81	1.63
Levered Free Cash Flow Margin	-1.06	-0.45	-9.13	-8.12	-3.02
Unlevered Free Cash Flow Margin	-0.89	-0.33	-8.94	-7.84	-2.78
Asset Turnover
Asset Turnover	0.45	0.53	0.6	0.65	0.63
Fixed Assets Turnover	4.1	5.15	5.32	5.08	4.43
Receivables Turnover (Average Receivables)	5.62	6.6	6.13	5.64	5.39
Inventory Turnover (Average Inventory)	1.22	1.28	1.31	1.45	1.36
Short Term Liquidity
Current Ratio	2.12	2.28	2.23	2.02	2.03
Quick Ratio	1.33	1.47	1.17	1.05	0.95
Operating Cash Flow to Current Liabilities	0.02	0.1	0	0.09	0.16
Days Sales Outstanding (Average Receivables)	64.99	55.29	59.51	64.85	67.71
Days Outstanding Inventory (Average Inventory)	298.04	285.41	277.97	252.8	268.23
Average Days Payable Outstanding	83.04	74.83	64.43	66.86	71.11
Cash Conversion Cycle (Average Days)	279.99	265.86	273.05	250.79	264.82
Long Term Solvency
Total Debt/Equity	24.89	21.68	21.67	24.33	30.28
Total Debt / Total Capital	19.93	17.82	17.81	19.57	23.24
LT Debt/Equity	19.33	15.45	17.41	11.44	19.11
Long-Term Debt / Total Capital	15.48	12.7	14.3	9.2	14.67
Total Liabilities / Total Assets	45.57	42.29	41.12	40.28	42.44
EBIT / Interest Expense	-22.11	43.79	29.15	13.17	5.66
EBITDA / Interest Expense	0.38	67.37	43.81	24.33	22.14
(EBITDA - Capex) / Interest Expense	-13.24	50.31	32.13	12.06	2.68
Total Debt / EBITDA	282.85	1.83	1.54	2.14	3.26
Net Debt / EBITDA	-459.34	-3.38	-0.89	-0.51	0.51
Total Debt / (EBITDA - Capex)	-8.13	2.45	2.1	4.33	26.91
Net Debt / (EBITDA - Capex)	13.2	-4.53	-1.21	-1.04	4.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-23.65	19.59	16.4	14.19	-0.27
Gross Profit, 1 Yr. Growth %	-29.78	51.42	22.49	7.22	0.62
EBITDA, 1 Yr. Growth %	-99.07	14.88K	22.28	-10.48	-23.64
EBITA, 1 Yr. Growth %	-261.04	-267.5	25.18	-27.19	-63.94
EBIT, 1 Yr. Growth %	-261.04	-267.5	25.18	-27.19	-63.94
Earnings From Cont. Operations, 1 Yr. Growth %	-540.07	-222.44	2.44	-25.76	-80.95
Net Income, 1 Yr. Growth %	-548.42	-223.72	5.31	-27.53	-81.2
Normalized Net Income, 1 Yr. Growth %	-198.12	-314.46	32.18	-30.15	-57.32
Diluted EPS Before Extra, 1 Yr. Growth %	-573.35	-223.01	7.95	-25.04	-81
Accounts Receivable, 1 Yr. Growth %	-16.95	24.24	26.13	22.48	-10.35
Inventory, 1 Yr. Growth %	-4.37	1.35	16.04	2.87	7.82
Net Property, Plant and Equip., 1 Yr. Growth %	-19.07	13.03	12.12	26.56	4.65
Total Assets, 1 Yr. Growth %	-1.6	5.03	1.03	9.22	-3.19
Tangible Book Value, 1 Yr. Growth %	-0.05	11.1	-13.28	10.46	-10.04
Common Equity, 1 Yr. Growth %	-0.57	11.18	2.89	11.19	-6.7
Cash From Operations, 1 Yr. Growth %	-69.75	531.31	-99.95	205K	56.85
Capital Expenditures, 1 Yr. Growth %	-12.83	5.99	28.69	69.47	33.02
Levered Free Cash Flow, 1 Yr. Growth %	-26.99	-48.89	2.24K	1.47	-62.94
Unlevered Free Cash Flow, 1 Yr. Growth %	-26.87	-55.37	3.03K	0.15	-64.61
Dividend Per Share, 1 Yr. Growth %	-50	100	12.5	11.11	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-20.2	-4.45	17.98	15.29	6.71
Gross Profit, 2 Yr. CAGR %	-28.32	3.11	36.19	14.6	3.87
EBITDA, 2 Yr. CAGR %	-93.51	17.75	1.25K	4.63	-17.32
EBITA, 2 Yr. CAGR %	-42.95	64.24	44.8	-4.53	-48.76
EBIT, 2 Yr. CAGR %	-42.95	64.24	44.8	-4.53	-48.76
Earnings From Cont. Operations, 2 Yr. CAGR %	-28.01	132.12	11.99	-12.79	-62.39
Net Income, 2 Yr. CAGR %	-27.98	135.54	14.14	-12.64	-63.09
Normalized Net Income, 2 Yr. CAGR %	-50.28	45.06	68.37	-3.91	-45.4
Diluted EPS Before Extra, 2 Yr. CAGR %	-25.06	141.3	15.23	-10.04	-62.26
Accounts Receivable, 2 Yr. CAGR %	-20.67	1.58	25.18	24.29	4.79
Inventory, 2 Yr. CAGR %	-3.53	-1.55	8.45	9.26	5.31
Net Property, Plant and Equip., 2 Yr. CAGR %	-7.93	-4.36	12.57	19.12	15.09
Total Assets, 2 Yr. CAGR %	-6.62	1.66	3.01	5.05	2.83
Tangible Book Value, 2 Yr. CAGR %	-5.85	5.38	-1.84	-2.13	-0.31
Common Equity, 2 Yr. CAGR %	-6.58	5.14	6.96	6.96	1.85
Cash From Operations, 2 Yr. CAGR %	-73.15	38.18	-94.5	-0.94	5.57K
Capital Expenditures, 2 Yr. CAGR %	-9.75	-3.88	16.79	47.68	50.14
Levered Free Cash Flow, 2 Yr. CAGR %	-52.41	-38.91	245.74	387.15	-38.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	-57.39	-42.87	273.64	459.75	-40.46
Dividend Per Share, 2 Yr. CAGR %	-42.26	0	50	11.8	5.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-14.31	-8.68	2.05	16.71	9.85
Gross Profit, 3 Yr. CAGR %	-20.72	-8.02	9.21	25.75	9.74
EBITDA, 3 Yr. CAGR %	-83.01	-14.21	19.24	447.36	-5.8
EBITA, 3 Yr. CAGR %	-24.88	-18.31	50.03	15.15	-30.99
EBIT, 3 Yr. CAGR %	-24.88	-18.31	50.03	15.15	-30.99
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.31	-14.07	76.73	-2.35	-47.47
Net Income, 3 Yr. CAGR %	-0.26	-13.75	80.1	-1.9	-47.65
Normalized Net Income, 3 Yr. CAGR %	-30.6	-19.06	40.64	25.57	-26.68
Diluted EPS Before Extra, 3 Yr. CAGR %	2.41	-11.6	84.55	-0.15	-46.43
Accounts Receivable, 3 Yr. CAGR %	-11.32	-7.88	9.18	24.28	11.47
Inventory, 3 Yr. CAGR %	0.03	-1.93	4	6.56	8.77
Net Property, Plant and Equip., 3 Yr. CAGR %	-6.06	-1.41	0.85	17.05	14.09
Total Assets, 3 Yr. CAGR %	-3.41	-2.88	1.45	5.04	2.22
Tangible Book Value, 3 Yr. CAGR %	-1.21	-0.51	-1.25	2.1	-4.84
Common Equity, 3 Yr. CAGR %	-2.1	-1	4.39	8.35	2.2
Cash From Operations, 3 Yr. CAGR %	-65.89	-23.09	-90.3	83.66	15.46
Capital Expenditures, 3 Yr. CAGR %	-15.44	-4.78	5.94	32.22	42.62
Levered Free Cash Flow, 3 Yr. CAGR %	-58.93	-51.27	105.89	129.76	106.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-61.45	-56.73	116.94	140.91	122.99
Dividend Per Share, 3 Yr. CAGR %	-17.79	-12.64	4	35.72	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-11.32	-6.35	-2.61	0.24	3.89
Gross Profit, 5 Yr. CAGR %	-13.27	-5.06	-1.57	0.43	7.04
EBITDA, 5 Yr. CAGR %	-63.63	-5.05	-2.13	-7.12	3
EBITA, 5 Yr. CAGR %	-5.57	-4.48	-2.33	-13.05	-2.38
EBIT, 5 Yr. CAGR %	-5.57	-4.48	-2.33	-13.05	-2.38
Earnings From Cont. Operations, 5 Yr. CAGR %	9.13	59.78	4.44	-13.56	-4.83
Net Income, 5 Yr. CAGR %	9.22	60.82	5.27	-13.31	-4.46
Normalized Net Income, 5 Yr. CAGR %	-12.37	-4.39	-1.07	-13.31	-3.67
Diluted EPS Before Extra, 5 Yr. CAGR %	10.96	63.21	7.36	-10.98	-2.19
Accounts Receivable, 5 Yr. CAGR %	-5.47	-1.2	1.79	3.85	7.4
Inventory, 5 Yr. CAGR %	-0.96	1.63	3.32	2.4	4.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-5.06	-1.8	0.99	6.34	6.32
Total Assets, 5 Yr. CAGR %	0.91	0.41	-0.89	0.21	2
Tangible Book Value, 5 Yr. CAGR %	0.7	3.14	-1.47	-1.16	-0.88
Common Equity, 5 Yr. CAGR %	-0.11	2.14	1.43	2.11	3.37
Cash From Operations, 5 Yr. CAGR %	-45.7	-20.28	-83.59	-14.89	24.06
Capital Expenditures, 5 Yr. CAGR %	-5.03	-3.33	-3.78	13.49	21.8
Levered Free Cash Flow, 5 Yr. CAGR %	-40.68	-56.33	-3.71	22.39	26.83
Unlevered Free Cash Flow, 5 Yr. CAGR %	-42.89	-59.02	-4.37	20.49	29.33
Dividend Per Share, 5 Yr. CAGR %	2.13	20.11	4.56	-3.58	4.56